Saturday 17 October 2026
Export MBX’s income statement to Excel — free account
MBX Biosciences, Inc.
In the quarter to June 2026, EPS fell 34.5% and free cash flow fell 29.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
49.61
1.10
−2.17%
Follow MBX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
24.62 | 24.19 | 21.26 | 12.89 |
Net Debt/EBITDA |
3.82 | 3.86 | 2.29 | 1.69 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.92 | 0.88 | 0.98 | 0.88 |
Capex/Depreciation |
(7.78) | (3.58) | (0.82) | (7.87) |
Interest Coverage |
— | — | — | (67.28) |
| (27.76%) | (66.95%) | 56.60% | 0.00% | |
| (26.61%) | (35.11%) | (50.38%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(23.58%) | (24.06%) | (40.71%) | (63.28%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.24) | (5.22) | (31.51) | (35.33) |
Cash per Share |
10.24 | 24.63 | 79.17 | 63.66 |
Shareholders Equity per Share |
10.11 | 24.19 | (71.12) | (63.88) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.11 | 24.19 | (71.12) | (63.88) |
Free Cash Flow |
(81.88) | (55.55) | (32.11) | (23.56) |
Working Capital |
366.04 | 256.24 | 79.54 | 40.78 |
Capital Expenditures |
(1.93) | (0.87) | (0.13) | (0.44) |
Net Current Asset Value |
365.62 | 256.19 | (73.18) | (43.49) |
| Other line items | ||||
Quick Ratio |
24.12 | 23.72 | 20.55 | 12.38 |
Depreciation/Fixed assets |
0.09 | 0.23 | 0.36 | 0.11 |
Cash ROIC |
(11.02%) | (10.69%) | (391.17%) | 16,363.19% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.19) | (5.14) | (31.38) | (34.67) |
Capex per Share |
(0.05) | (0.08) | (0.13) | (0.66) |
Average Payables |
4.16 | 3.36 | 1.18 | — |
Average Assets |
326.84 | 176.36 | 64.64 | — |
Average Common Equity |
313.33 | 92.49 | (57.54) | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates